ConductScience.org, home

Paper3308166

Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

Uretsky BF and 8 others. Circulation, 1987. Cited by 559 papers, by iCite.

Cite this record

ConductScience Library. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Papers, record 3308166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3308166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
PubMed
Journal
Circulation
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
559
iCite
Relative citation ratio, by iCite
20.5
iCite
Revised in PubMed
2019-06-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uretsky BFB F
2Murali SS
3Reddy PSP S
4Rabin BB
5Lee AA
6Griffith BPB P
7Hardesty RLR L
8Trento AA
9Bahnson HTH T

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary DiseaseMajor topic
CyclosporinsMajor topic
Heart TransplantationMajor topic
Postoperative ComplicationsMajor topic
PrednisoneMajor topic
Adult
Coronary Angiography
Coronary Vessels
Graft Rejection
Humans
Middle Aged
Risk Factors
Time Factors

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT02597543Stress Cardiac MRI for Evaluation of Nonspecific Allograft DysfunctionBackgroundClinicalTrials.gov
NCT03102125Allograft Dysfunction in Heart TransplantResultsClinicalTrials.gov

Download CSV of trials

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 559 citations.

PMIDTitleJournalYearIn PapersSource
40014294Echocardiographic Evaluation of the Post-Heart Transplant Patient.Curr Cardiol Rep2025https://conductscience.org/library/papers/40014294PubMed
39025897Explainable drug repurposing via path based knowledge graph completion.Sci Rep2024https://conductscience.org/library/papers/39025897PubMed
38559875Acute myocardial infarction in heart transplant recipients: An 18-year national study.Am Heart J Plus2022https://conductscience.org/library/papers/38559875PubMed
37306271An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant.Anaesthesiol Intensive Ther2023https://conductscience.org/library/papers/37306271PubMed
34950505Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy.Card Fail Rev2021https://conductscience.org/library/papers/34950505PubMed
32644975Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection.J Clin Invest2020https://conductscience.org/library/papers/32644975PubMed
29524240Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.J Clin Apher2018https://conductscience.org/library/papers/29524240PubMed
28747943The incidence of aspirin resistance in heart transplantation recipients.Kardiochir Torakochirurgia Pol2017https://conductscience.org/library/papers/28747943PubMed
24700094Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.World J Surg2014https://conductscience.org/library/papers/24700094PubMed
24551271Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.Int J Clin Exp Pathol2014https://conductscience.org/library/papers/24551271PubMed
21442262Magnetic resonance assessment of left ventricular diastolic dysfunction for detecting cardiac allograft vasculopathy in recipients of heart transplants.Int J Cardiovasc Imaging2012https://conductscience.org/library/papers/21442262PubMed
20615726Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.J Heart Lung Transplant2010https://conductscience.org/library/papers/20615726PubMed
19047995Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition.Nat Clin Pract Cardiovasc Med2009https://conductscience.org/library/papers/19047995PubMed
17100772Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimal hyperplasia.Clin Exp Immunol2006https://conductscience.org/library/papers/17100772PubMed
16510046Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation.Curr Atheroscler Rep2006https://conductscience.org/library/papers/16510046PubMed
16149368Cardiac allograft vasculopathy: a review.Can J Surg2005https://conductscience.org/library/papers/16149368PubMed
15215168Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.Am J Pathol2004https://conductscience.org/library/papers/15215168PubMed
15215157Mouse models of arteriosclerosis: from arterial injuries to vascular grafts.Am J Pathol2004https://conductscience.org/library/papers/15215157PubMed
13680240Exercise after heart transplantation.Eur J Appl Physiol2003https://conductscience.org/library/papers/13680240PubMed
12955268[Perioperative implications of heart transplant].Anaesthesist2003https://conductscience.org/library/papers/12955268PubMed

See all 60 cited byDownload CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
REGADENOSONCHEMBL3989695Results1https://conductscience.org/library/drugs/CHEMBL3989695

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3308166

GET https://conductscience.org/api/papers/v1/3308166/cited_by?page=2